Editor - Gemma Eminowicz | Imperial College London | 23334

Insights in Gynecologic Oncology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Gemma Eminowicz

Gemma Eminowicz
Gemma Eminowicz
Gynecological Clinical Oncologist
Imperial College London
London, UK


Dr Gemma Eminowicz is a Gynecological Clinical Oncologist and brachytherapy lead at Imperial College London Healthcare NHS Trust, UK. She is also a Senior Clinical Lecturer at Imperial College London. Having undergone oncology training in Hampshire, Dorset and London and completed the Fellowship of Royal College of Radiology (Clinical Oncology) in 2011, Dr Gemma Eminowicz pursued a career specializing in gynecological oncology and brachytherapy. She undertook an MD(Res) within the field of cervical radiation at University College London which was awarded in 2016. This two-year research degree studied the impact of target volume delineation variation and pelvic organ motion during radiotherapy on dose delivered in cervical cancer leading to 5 publications. During this MD(Res) Gemma undertook a placement at AKH, Vienna, under the supervision of Professor Richard Potter. In addition to her clinical work she actively participates in international radiotherapy trials for gynecological cancer and is a member of the TMG and RTTQA team for INTERLACE. She is also chief investigator of a study investigating the use of PET-MRI in chemoradiation for cervical cancer and is a regular reviewer for high impact radiotherapy and gynecology journals.

Research Interest

optimization of radiotherapy for gynecological cancer, brachytherapy for pelvic cancers, adaptive radiotherapy using biological target volumes.




Current Issues in Cervical Cancer Radiotherapy

Gemma Eminowicz
Editorial: Trends Gynecol Oncol 2016, 2:e104